• group versus 61 (30%) of 202 patients in the intravenous cisplatin group (p=0·01).

    Oral metronomic chemotherapy is non-inferior to intravenous cisplatin with respect to overall survival in head and neck cancer in the palliative setting, and is associated with fewer adverse events. It therefore represents a new alternative standard of care…[Read more]

  • n decrease in appetite” (2/8, 25%), “unwilling or reluctant to sit” (2/8, 25%), and “handler-reported unusual behaviors” (2/8, 25%). Findings from this preliminary study supported inclusion of multi-level LS stenosis in the differential diagnosis list for military working dogs presenting with a recent onset of behavioral problems.Aim To evaluate…[Read more]

  • Berthelsen Arsenault became a registered member 7 months ago